Given a paragraph, generate a claim that is supported by the given paragraph. 1) The claim must contain information from within the paragraph. 2) A sentence within the paragraph can be used as a claim. 3) The claim should not have contradictions within the paragraph. 4) The claim should be at most one sentence long.

Example Input: A nun attends a mass led by Pope Benedict XVI at the Garden of Gethsemane at the foot of the Mount of Olives in Jerusalem May 12, 2009, where it is believed Jesus had his final prayer before he was betrayed and arrested. REUTERS/Baz Ratner The vow of chastity taken by the world’s 95,000 Catholic nuns carries with it an increased risk of breast, ovarian and uterine cancers — all of which are more common in women who do not have children. It is a problem that has been recognized for hundreds of years. In 1713, Italian physician Bernadino Ramazzini reported nuns had extremely high rates of the “accursed pest,” breast cancer. Kara Britt of Monash University and Roger Short of the University of Melbourne, writing in The Lancet medical journal, argued that taking modern contraceptive pills could be one answer. Lack of pregnancy and lactation means childless women have more menstrual cycles, which increases cancer risk, while those who have children further decrease their risk if they have first babies while young, have several children and breastfeed. Overall mortality in women using the contraceptive pill is around 12 percent lower than in those who have never used it and the risk of developing ovarian and endometrial cancers falls by 50 to 60 percent, the authors said. “If the Catholic Church could make the oral contraceptive pill freely available to all its nuns, it would reduce the risk of those accursed pests, cancer of the ovary and uterus, and give nuns’ plight the recognition it deserves,” the doctors said. Although the Catholic Church condemns all forms of contraception, barring abstinence, the doctors argued that using the pill might still be possible under regulations on birth control set out by Pope Paul VI in Humanae Vitae in 1968. This document stated that “the Church in no way regards as unlawful therapeutic means considered necessary to cure organic diseases, even though they also have a contraceptive effect.”   Of course, the pill can also carry its own dangers, such as the risk of blood clots with the combined oestrogen-progestogen version, so the suitability of nuns would have to be assessed according to their individual medical histories, the doctors added.
Example Output: Vow of chastity and the pill may keep nuns healthy.

Example Input: China has been investigating 17 deaths following inoculation with a hepatitis B vaccine, made by Shenzhen-based BioKangtai, from December 13 and 31. The news alarmed many Chinese Internet users, who called on the government to make more information public. Many Chinese people are suspicious that the government tries to cover up bad news about health problems, despite assurances of transparency. In 2003, the government initially tried to cover-up the outbreak of the SARS virus. Nine of the cases have nothing to do with the vaccines, state news agency Xinhua cited the director of the disease control bureau of the National Health and Family Planning Commission, Yu Jingjin, as saying at a press conference. A preliminary analysis of the eight other cases have also found no link between the deaths and the vaccines, but the cause of the deaths will be confirmed only after autopsies, Yu said. Li Guoqing of the China Food and Drug Administration said at a press conference that no problems had been found with BioKangtai vaccines in production practices or product quality, according to Xinhua. BioKangtai said in a statement in December that it rigorously followed safety rules but that they were testing the batches suspected of causing the deaths. China has been beset by a series of product safety scandals over the past few years. At least six children died in 2008 after drinking milk contaminated by the industrial chemical melamine, and there have also been reports of children dying or becoming seriously ill from faulty encephalitis, hepatitis B and rabies vaccines.
Example Output: China says child deaths not linked to hepatitis vaccine.

Example Input: U.S. scientists said the infection in a 49-year-old Pennsylvania woman “heralds the emergence of truly pan-drug resistant bacteria” because it could not be controlled even by colistin, an antibiotic reserved for “nightmare” bugs. In Japan, British Prime Minister David Cameron said leading countries needed to tackle resistance by reducing the use of antibiotics and rewarding drug companies for developing new medicines. “In too many cases antibiotics have stopped working. That means people are dying of simple infections or conditions like TB (tuberculosis), tetanus, sepsis, infections that should not mean a death sentence,” he told a news conference at a summit in Japan. “If we do nothing about this there will be a cumulative hit to the world economy of $100 trillion and it is potentially the end of modern medicine as we know it.”  A review commissioned by the British government and published last week said a reward of between $1 billion and $1.5 billion should be paid for any successful new antimicrobial medicine brought to market. If the problem is not brought under control, antimicrobial resistance could kill an extra 10 million people a year by 2050, the review warned. The U.S. case is a further wake-up call for the world, although it is not the first time that colistin resistance has appeared. Medics around were alarmed last year by the discovery in China of a new gene that makes bacteria highly resistant to the medicine. Since then, the deadly strain has also been detected in Europe and Canada. The development of colistin resistance is linked to the drug’s widespread use in livestock and the European Medicines Agency on Thursday called for a 65 percent cut in the amount of the medicine used in farming. “The more we look at drug resistance, the more concerned we are,” Thomas Frieden, director of the U.S. Centers for Disease Control and Prevention, told reporters in Washington. “The medicine cabinet is empty for some patients. It is the end of the road for antibiotics unless we act urgently.”  The problem is aggravated by drugmakers’ reluctance to invest in developing new antibiotics, preferring to focus on more profitable disease areas, although recently there has been some increase in investment, prompted by the superbug threat. In January, 83 companies, including Pfizer (PFE.N), Merck & Co (MRK.N), Johnson & Johnson (JNJ.N) and GlaxoSmithKline (GSK.L), signed a declaration urging governments to support work on new antibiotics.
Example Output:
G7 told to act on antibiotics as dreaded superbug hits U.S.